Piper Sandler on Procept BioRobotics Corp (PRCT): 'Compelling Setup Ahead of Near-Term Catalysts'
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $100.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
